Analysis of the biological effect of Carica papaya leaf extracts on the viability and proliferation of K562 cells
DOI:
https://doi.org/10.25758/set.663Keywords:
Carica papaya, Fetal hemoglobin, Sickle cell disease, Natural compoundsAbstract
Background – Sickle cell disease (SCD) is a genetic blood disorder caused by mutations in the β-globin gene that affects the shape and transport of red blood cells in blood vessels, leading to various clinical complications. The pharmacological reactivation of fetal hemoglobin (HbF) through compounds such as hydroxyurea (HU), is one of the currently available treatments, however, their safety concerns and expensive cost in low- and middle-Income countries limit their use. In this context, it is essential to study novel HbF-inducing compounds that have scarcer adverse effects and can be widely available, such as Carica papaya leaf (CP) extracts, a medicinal plant with anti-oxidant and anti-inflammatory properties. Aim of the study – Evaluate the effect of CP methanolic leaf extracts (CPMLE) on biological parameters such as cell proliferation and viability on the K562 cell line. Methods – K562 cells were exposed for 72 hours to CPMLE at 500 µg/mL and for 24 hours to CPMLE (0.5; 50; 100 µg/mL) and HU (25 μg/mL). Cell proliferation and viability after CPMLE exposure were analyzed by cell counting. Results – The results demonstrate that cell proliferation and viability were affected by CPMLE only at the concentration of 500 µg/mL, with no effects being observed at the lower concentrations analysed. Conclusion – Our results showed that CPMLE is not cytotoxic when incubated at concentrations equal to or below 100 μg/mL thus allowing us to explore this compound in the evaluation of its therapeutic potential, in the context of sickle cell anemia treatment.
Downloads
References
Carden MA, Little J. Emerging disease-modifying therapies for sickle cell disease. Haematologica. 2019;104(9):1710-9.
Zittersteijn HA, Harteveld CL, Klaver-Flores S, Lankester AC, Hoeben RC, Staal FJ, et al. A small key for a heavy door: genetic therapies for the treatment of hemoglobinopathies. Front Genome Ed. 2021;2: 617780.
World Health Organization. Sickle-cell anaemia: report by the Secretariat [homepage]. Geneva: WHO; 2006. Available from: https://apps.who.int/iris/handle/10665/20890
Mussolino C, Strouboulis J. Recent approaches for manipulating globin gene expression in treating hemoglobinopathies. Front Genome Ed. 2021;3:618111.
Pabuprapap W, Wassanatip Y, Khetkam P, Chaichompoo W, Kunkaewom S, Senabud P, et al. Quercetin analogs with high fetal hemoglobin-inducing activity. Med Chem Res. 2019;28(10):1755-65.
Yu L, Myers G, Engel JD. Small molecule therapeutics to treat the β-globinopathies. Curr Opin Hematol. 2020;27(3):129-40.
Eridani S, Avemaria F, Mosca A. Reactivation of fetal hemoglobin in thalassemia and sickle cell disease. Thalassemia Rep. 2014;4(2):2196.
Paikari A, Sheehan VA. Fetal haemoglobin induction in sickle cell disease. Br J Haematol. 2018;180(2):189-200.
Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.
Singh SP, Kumar S, Mathan SV, Tomar MS, Singh RK, Verma PK, et al. Therapeutic application of Carica papaya leaf extract in the management of human diseases. DARU. 2020;28(2):735-44.
Mukherjee M, Rahaman M, Ray SK, Shukla PC, Dolai TK, Chakravorty N. Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies. Mol Biol Rep. 2022;49(3):2359-73.
Karunamoorthi K, Min KH, Jegajeevanram K, Xavier J, Vijayalakshmi J. Papaya: a gifted nutraceutical plant (a critical review of recent human health research). CellMed. 2014;4(1):e2.
Vij T, Prashar Y. A review on medicinal properties of Carica papaya Linn. Asian Pac J Trop Dis. 2015;5(1):1-6.
Maia MF. Propriedades biológicas das sementes da papaia (Carica papaya L.): valorização de um resíduo alimentar [dissertation]. Porto: Universidade Fernando Pessoa; 2017.
Anuar NS, Zahari SS, Taib IA, Rahman MT. Effect of green and ripe Carica papaya epicarp extracts on wound healing and during pregnancy. Food Chem Toxicol. 2008;46(7):2384-9.
Imaga NA. Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia. Sci World Journal. 2013;2013:269659.
Naiho AO, Okonkwor BC, Okoukwu C. Anti-sickling and membrane stabilizing effects of Carica papaya leaf extract. Br J Med Med Res. 2015;6(5):484-92.
Li J, Lai Y, Shi L. BCL11A down-regulation induces γ-globin in human β-thalassemia major erythroid cells. Hemoglobin. 2018;42(4):225-30.
Qian X, Chen J, Zhao D, Guo L, Qian X. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway. Int J Mol Med. 2013;31(6):1418-28.
Khosravi MA, Abbasalipour M, Concordet JP, Berg JV, Zeinali S, Arashkia A, et al. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: a promising approach for gene therapy of beta thalassemia disease. Eur J Pharmacol. 2019;854:398-405.
Nugroho A, Heryani H, Choi JS, Park HJ. Identification and quantification of flavonoids in Carica papaya leaf and peroxynitrite-scavenging activity. Asian Pac J Trop Biomed. 2017;7(3):208-13.
Ismail Z, Halim SZ, Abdullah NR, Afzan A, Rashid BA, Jantan I. Safety evaluation of oral toxicity of Carica papaya Linn. Leaves: a subchronic toxicity study in sprague dawley rats. Evid Based Complement Alternat Med. 2014;2014:741470.
Gardner RV. Sickle cell disease: advances in treatment. Ochsner J. 2018;18(4):377-89.
Ribeiro E, Delgadinho M, Matos E, Santos R, Sousa D, Galante H, et al. Epigenetic and transcriptional modulator potential of Epigallocatechin-3-gallate and genistein on fetal hemoglobin reactivators genes. Clin Complement Med Pharmacol. 2022;2(2):100034.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Saúde e Tecnologia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The journal Saúde & Tecnologia offers immediate free access to its content, following the principle that making scientific knowledge available to the public free of charge provides greater worldwide democratization of knowledge.
The journal Saúde & Tecnologia does not charge authors any submission or article processing charges (APC).
All content is licensed under a Creative Commons CC-BY-NC-ND license. Authors have the right to: reproduce their work in physical or digital form for personal, professional, or teaching use, but not for commercial use (including the sale of the right to access the article); deposit on their website, that of their institution or in a repository an exact copy in electronic format of the article published by Saúde & Tecnologia, provided that reference is made to its publication in Saúde & Tecnologia and its content (including symbols identifying the journal) is not altered; publish in a book of which they are authors or editors the total or partial content of the manuscript, provided that reference is made to its publication in Saúde & Tecnologia.
